86.7%
faricimabafliberceptranibizumabVabysmodiabetic macular oedemaretinal diseasesretinal vein occlusionAMDDME
…r centre’s experience.Aim and Objectives To evaluate the use of faricimab and its economic impact from the hospital pharmacy perspective.…